Update on Dexamethasone for the Treatment of COVID-19

Update on Dexamethasone for the Treatment of COVID-19

Few treatments have proven to be effective for treating COVID-19. Recently, a clinical trial reporting the results of dexamethasone for treating COVID-19 was published and has received a great deal of attention in the popular media. Greg Curfman, MD, JAMA Deputy Editor, reviews the study and discusses what the findings do or do not reveal about the efficacy of dexamethasone for treating COVID-19.

Related Article(s):

Missed Opportunities on Emergency Remdesivir Use

Jaksot(227)

COVID-19 CDC Update – Early January 2022

COVID-19 CDC Update – Early January 2022

Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boos...

11 Tammi 202232min

COVID-19 Update: Omicron Variant

COVID-19 Update: Omicron Variant

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a ...

6 Joulu 202138min

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms

Interview with Cédric Lemogne, MD, PhD, and Joane Matta, PhD, authors of Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among Fr...

8 Marras 202127min

October 2021 Medical News Summary

October 2021 Medical News Summary

COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes; Moving COVID-19 Testing Out of the Clinic and Into the Home; The Lingua Franca of Addiction—Stigmatizing Words That Wound Related Content: ...

26 Loka 202120min

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Pa...

7 Loka 202117min

A New Vision for Nursing Homes

A New Vision for Nursing Homes

The longstanding shortcomings of the US nursing home model became more visible during the COVID-19 crisis. Terry Fulmer, PhD, RN, a geriatric nurse practitioner and president of the John A. Hartford F...

6 Loka 202124min

COVID-19 in Canada—Experience and Response to Waves 2 and 3

COVID-19 in Canada—Experience and Response to Waves 2 and 3

Canadian law gives the country's individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the Universi...

28 Syys 202123min

Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic

Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic

Interview with Grayson W. Armstrong, MD, MPH, author of Association of Patient Characteristics With Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic, and Fasika Ambachew Woreta, MD, MP...

23 Syys 202116min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-tiedetta-vai-tarinaa
rss-duodecim-lehti
rss-lihavuudesta-podcast
utelias-mieli
radio-antro
filocast-filosofian-perusteet
university-of-eastern-finland
docemilia
hippokrateen-vastaanotolla
rss-kasvatuspsykologiaa-kaikille
rss-astetta-parempi-elama-podcast
rss-tervetta-skeptisyytta
rss-lapsuuden-rakentajat-podcast
rss-sosiopodi